FDA Approved: ALDURAZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for Aldurazyme (laronidase) from Genzyme Corporation. This constitutes a supplemental approval of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome
• Hurler-scheie Syndrome
• Mucopolysaccharidosis Type
• Scheie Syndrome

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

SUPPL AP for ALDURAZYME (LARONIDASE)